He is the lead principal investigator of the ALLEGORY study and the lead author and he has also presented the results last Friday at SLEuro. Today, Dr. Richard Furie will take us again through the ...

Precision Bb Targeting, Robust Efficacy, Transfusion Independence, Excellent Safety in Phase II PNH Study, and Subcutaneous Administration The 12-16-week open-label study evaluated Ruxoprubart as ...

After a huge debut show in 2024, Factor B will be back in February — bringing a massive 4-hour Theatre Of The Mind - Bloom set to Auckland. Prepare to step inside the Theatre of the Mind — an ...